Inhibition of p38 kinase using substituted heterocyclic ureas
1998
(57) Abstract: The present invention is the use of a group of urea in the treatment of proteolytic enzymes mediated diseases other than cytokine-mediated diseases and cancer than cancer, and to pharmaceutical compositions for use in such treatment .
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI